Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole vs caspofungin for empirical antifungal therapy in febrile neutropenia
CTR20160816Phase 4Completed
- Sponsor
- Janssen-Cilag
- Start
- Nov 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of itraconazole in febrile neutropenia (FN), invasive mycoses, mycoses, sponsored by Janssen-Cilag. Started Nov 2016; status: completed.
02
Drugs
itraconazole
03
Conditions
febrile neutropenia (FN)invasive mycosesmycoses
Beyond the preview
Go deeper on CTR20160816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160816.